This topic contains a solution. Click here to go to the answer

Author Question: In this study the independent variable was a. Which drug the groups were given b. The incidence ... (Read 14 times)

PhilipSeeMore

  • Hero Member
  • *****
  • Posts: 561
In this study the independent variable was
 
  a. Which drug the groups were given
  b. The incidence of hay fever
  c. The age of the subjects
  d. The gender of the subjects.

Question 2

When doing the ordinal T test, it is important to establish
 
  a. the signed ranks
  b. frequency of occurrence
  c. the difference between the means
  d. all of these



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

marict

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

a

Answer to Question 2

Awesome job my friend




PhilipSeeMore

  • Member
  • Posts: 561
Reply 2 on: Jun 20, 2018
Thanks for the timely response, appreciate it


FergA

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library